GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Idorsia Ltd (OTCPK:IDRSF) » Definitions » Other Current Payables

Idorsia (Idorsia) Other Current Payables : $0.0 Mil (As of Sep. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Idorsia Other Current Payables?

Idorsia's Other Current Payables for the quarter that ended in Sep. 2023 was $0.0 Mil.

Idorsia's annual Other Current Payables increased from Dec. 2020 ($1.4 Mil) to Dec. 2021 ($7.5 Mil) but then declined from Dec. 2021 ($7.5 Mil) to Dec. 2022 ($6.6 Mil).


Idorsia Other Current Payables Historical Data

The historical data trend for Idorsia's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Idorsia Other Current Payables Chart

Idorsia Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Other Current Payables
Get a 7-Day Free Trial 3.95 1.23 1.39 7.47 6.57

Idorsia Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.34 6.57 - - -

Idorsia Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.


Idorsia Other Current Payables Related Terms

Thank you for viewing the detailed overview of Idorsia's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.


Idorsia (Idorsia) Business Description

Traded in Other Exchanges
Address
Hegenheimermattweg 91, Allschwil, CHE, 4123
Idorsia Ltd is a biopharmaceutical company engaged in discovering, developing, and commercializing of medicines for unmet medical needs. It is a biotech hub of Europe specialized in the discovery and development of small molecules, to provide innovative therapeutic options. The company focuses on multiple therapeutic areas which include the central nervous system, cardiovascular disorders, immunological disorders, and orphan diseases. Idorsia's development compounds target a number of different diseases such as Resistant Hypertension, lupus, insomnia, Cerebral vasospasm, and Fabry disease. Geographically, it derives revenue from Switzerland.